AstraZeneca PLC (AZN) to Axe 1600 Jobs in Major R&D Overhaul
3/18/2013 8:01:21 AM
AstraZeneca is to cut around 1,600 jobs as it overhauls it research operations and consolidates drug development work in three major centres. The move will see the end of drug research at the company's Alderley Park facility in northern England, for many years a hub of the group's R&D efforts, the drugmaker said on Monday.
comments powered by